The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Interleukin 17A Market Research Report 2024
Synopsis
The global Interleukin 17A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interleukin 17A is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interleukin 17A is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A.
Report Scope
The Interleukin 17A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interleukin 17A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interleukin 17A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Segment by Type
ABY-035
CNTO-6785
DLX-2882
Others
Segment by Application
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interleukin 17A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Interleukin 17A market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Interleukin 17A is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Interleukin 17A is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A.
Report Scope
The Interleukin 17A market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interleukin 17A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interleukin 17A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Segment by Type
ABY-035
CNTO-6785
DLX-2882
Others
Segment by Application
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interleukin 17A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Interleukin 17A Market Overview
1.1 Product Overview and Scope of Interleukin 17A
1.2 Interleukin 17A Segment by Type
1.2.1 Global Interleukin 17A Market Value Comparison by Type (2024-2030)
1.2.2 ABY-035
1.2.3 CNTO-6785
1.2.4 DLX-2882
1.2.5 Others
1.3 Interleukin 17A Segment by Application
1.3.1 Global Interleukin 17A Market Value by Application: (2024-2030)
1.3.2 Chronic Pain
1.3.3 Liver Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Global Interleukin 17A Market Size Estimates and Forecasts
1.4.1 Global Interleukin 17A Revenue 2019-2030
1.4.2 Global Interleukin 17A Sales 2019-2030
1.4.3 Global Interleukin 17A Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interleukin 17A Market Competition by Manufacturers
2.1 Global Interleukin 17A Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interleukin 17A Average Price by Manufacturers (2019-2024)
2.4 Global Interleukin 17A Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interleukin 17A, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interleukin 17A, Product Type & Application
2.7 Interleukin 17A Market Competitive Situation and Trends
2.7.1 Interleukin 17A Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interleukin 17A Players Market Share by Revenue
2.7.3 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interleukin 17A Retrospective Market Scenario by Region
3.1 Global Interleukin 17A Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interleukin 17A Global Interleukin 17A Sales by Region: 2019-2030
3.2.1 Global Interleukin 17A Sales by Region: 2019-2024
3.2.2 Global Interleukin 17A Sales by Region: 2025-2030
3.3 Global Interleukin 17A Global Interleukin 17A Revenue by Region: 2019-2030
3.3.1 Global Interleukin 17A Revenue by Region: 2019-2024
3.3.2 Global Interleukin 17A Revenue by Region: 2025-2030
3.4 North America Interleukin 17A Market Facts & Figures by Country
3.4.1 North America Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interleukin 17A Sales by Country (2019-2030)
3.4.3 North America Interleukin 17A Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interleukin 17A Market Facts & Figures by Country
3.5.1 Europe Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interleukin 17A Sales by Country (2019-2030)
3.5.3 Europe Interleukin 17A Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interleukin 17A Market Facts & Figures by Country
3.6.1 Asia Pacific Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interleukin 17A Sales by Country (2019-2030)
3.6.3 Asia Pacific Interleukin 17A Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Interleukin 17A Market Facts & Figures by Country
3.7.1 Latin America Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interleukin 17A Sales by Country (2019-2030)
3.7.3 Latin America Interleukin 17A Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interleukin 17A Market Facts & Figures by Country
3.8.1 Middle East and Africa Interleukin 17A Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interleukin 17A Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interleukin 17A Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Interleukin 17A Sales by Type (2019-2030)
4.1.1 Global Interleukin 17A Sales by Type (2019-2024)
4.1.2 Global Interleukin 17A Sales by Type (2025-2030)
4.1.3 Global Interleukin 17A Sales Market Share by Type (2019-2030)
4.2 Global Interleukin 17A Revenue by Type (2019-2030)
4.2.1 Global Interleukin 17A Revenue by Type (2019-2024)
4.2.2 Global Interleukin 17A Revenue by Type (2025-2030)
4.2.3 Global Interleukin 17A Revenue Market Share by Type (2019-2030)
4.3 Global Interleukin 17A Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interleukin 17A Sales by Application (2019-2030)
5.1.1 Global Interleukin 17A Sales by Application (2019-2024)
5.1.2 Global Interleukin 17A Sales by Application (2025-2030)
5.1.3 Global Interleukin 17A Sales Market Share by Application (2019-2030)
5.2 Global Interleukin 17A Revenue by Application (2019-2030)
5.2.1 Global Interleukin 17A Revenue by Application (2019-2024)
5.2.2 Global Interleukin 17A Revenue by Application (2025-2030)
5.2.3 Global Interleukin 17A Revenue Market Share by Application (2019-2030)
5.3 Global Interleukin 17A Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AbbVie Inc Interleukin 17A Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Abeome Corporation
6.2.1 Abeome Corporation Corporation Information
6.2.2 Abeome Corporation Description and Business Overview
6.2.3 Abeome Corporation Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abeome Corporation Interleukin 17A Product Portfolio
6.2.5 Abeome Corporation Recent Developments/Updates
6.3 Affibody AB
6.3.1 Affibody AB Corporation Information
6.3.2 Affibody AB Description and Business Overview
6.3.3 Affibody AB Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Affibody AB Interleukin 17A Product Portfolio
6.3.5 Affibody AB Recent Developments/Updates
6.4 Cell Medica Limited
6.4.1 Cell Medica Limited Corporation Information
6.4.2 Cell Medica Limited Description and Business Overview
6.4.3 Cell Medica Limited Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cell Medica Limited Interleukin 17A Product Portfolio
6.4.5 Cell Medica Limited Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Corporation Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Eli Lilly and Company Interleukin 17A Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Interleukin 17A Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Merck KGaA
6.6.1 Merck KGaA Corporation Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Interleukin 17A Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Novartis AG
6.8.1 Novartis AG Corporation Information
6.8.2 Novartis AG Description and Business Overview
6.8.3 Novartis AG Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Novartis AG Interleukin 17A Product Portfolio
6.8.5 Novartis AG Recent Developments/Updates
6.9 Orega Biotech SAS
6.9.1 Orega Biotech SAS Corporation Information
6.9.2 Orega Biotech SAS Description and Business Overview
6.9.3 Orega Biotech SAS Interleukin 17A Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Orega Biotech SAS Interleukin 17A Product Portfolio
6.9.5 Orega Biotech SAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interleukin 17A Industry Chain Analysis
7.2 Interleukin 17A Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interleukin 17A Production Mode & Process
7.4 Interleukin 17A Sales and Marketing
7.4.1 Interleukin 17A Sales Channels
7.4.2 Interleukin 17A Distributors
7.5 Interleukin 17A Customers
8 Interleukin 17A Market Dynamics
8.1 Interleukin 17A Industry Trends
8.2 Interleukin 17A Market Drivers
8.3 Interleukin 17A Market Challenges
8.4 Interleukin 17A Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
